[1]王万晨,刘驰,袁铭杰,等.大黄素对黑素瘤细胞B16F10迁移的影响[J].中国皮肤性病学杂志,2020,(06):622-626.[doi:10.13735/j.cjdv.1001-7089.201908118]
 WANG Wanchen,LIU Chi,YUAN Mingjie,et al.Effects of Emodinon on Migration of B16F10 Melanoma Cells[J].The Chinese Journal of Dermatovenereology,2020,(06):622-626.[doi:10.13735/j.cjdv.1001-7089.201908118]
点击复制

大黄素对黑素瘤细胞B16F10迁移的影响
分享到:

《中国皮肤性病学杂志》[ISSN:1001-7089/CN:61-1197/R]

卷:
期数:
2020年06期
页码:
622-626
栏目:
论著
出版日期:
2020-06-01

文章信息/Info

Title:
Effects of Emodinon on Migration of B16F10 Melanoma Cells
文章编号:
1001-7089(2020)06-0622-05
作者:
王万晨刘驰袁铭杰陈亮刘天一
上海市复旦大学附属华东医院整形外科,上海 200040
Author(s):
WANG WanchenLIU ChiYUAN MingjieCHEN LiangLIU Tianyi
(Department of Plastic and Reconstructive Surgery,Huadong Hospital,FudanUniversity,Shanghai 200040,China)
关键词:
大黄素 黑素瘤 B16F10细胞 细胞迁移
Keywords:
Emodin Melanoma B16F10 melanoma cells Cell migration
分类号:
R 739.5
DOI:
10.13735/j.cjdv.1001-7089.201908118
文献标志码:
A
摘要:
目的 研究大黄素对黑素瘤细胞B16F10的迁移能力及NLRP3炎症小体相关蛋白表达的影响。方法 CCK-8试验、划痕愈合试验及Transwell迁移试验检测大黄素对黑素瘤细胞B16F10活性和迁移能力的影响,Western blot法检测大黄素对黑素瘤细胞B16F10中NLRP3炎症小体相关蛋白表达的影响。结果 CCK-8试验显示,与对照组相比,使用不同浓度大黄素处理24 h及48 h后,黑素瘤B16F10细胞的细胞活性受到明显抑制(P<0.05)。划痕愈合试验结果显示,与对照组相比,使用20、40、60 μmol/L大黄素处理后,黑素瘤B16F10细胞的划痕愈合能力显著下降。Transwell试验显示,与对照组相比,使用20、40、60 μmol/L大黄素处理24 h后,穿过隔膜的细胞明显减少(P<0.05),提示大黄素可以抑制黑素瘤B16F10细胞的迁移能力。Western blot结果显示,与对照组相比,使用20、40、60 μmol/L大黄素处理24 h后,NLRP3蛋白的表达水平明显下降。结论 大黄素可抑制黑素瘤细胞B16F10细胞的迁移能力,其机制可能与NLRP3炎症小体相关蛋白的下调有关。
Abstract:
Objective To investigate the effects of emodin on the migration of human B16F10 melanoma cells and the expression of NLRP3.Methods CCK-8 assay,wound healing assay and transwell assay were used to detect the effect of emodin on the cell viability and migration ability of B16F10 cells.Western blot was used to detect the effect of emodin on the expression of NLRP3 in B16F10 melanoma cells.Results CCK-8 assay showed that emodin reduced cell viability(P<0.05)compared with the control group after treatment with various concentrations of emodin for 24 hours and 48 hours.Results of wound healing assays showed that the wound healing area was significantly reduced compared with the control group after treatment with 20,40 and 60 μmol/L of emodin.Transwell assay showed that the number of transmembrane cells was decreased significantly after being treated with 20,40 and 60 μmol/L of emodin for 24 hours(P < 0.05),indicating that emodin was able to inhibit cell migration of B16F10 cells.The result of Western blot showed that the expression level of NLRP3 protein was decreased significantly after treatment with 20,40 and 60 μmol/L of emodin.Conclusion Emodin can inhibit the migration ability of B16F10 cells,which may involve the down-regulation of inflammasome relative proteins including NLRP3.

参考文献/References:

[1] Prado G,Svoboda RM,Rigel DS.What's new in melanoma[J].Dermatol Clin,2019,37(2):159-168.
[2] 王丽,栗玉珍.黑素瘤的分子发病机制和靶向治疗新进展[J].中国皮肤性病学杂志,2012,26(2):164-166,174.
[3] Schvartsman G,Taranto P,Glitza IC,et al.Management of metastatic cutaneous melanoma:updates in clinical practice[J].Ther Adv Med Oncol,2019,11:1758835919851663.
[4] Arozarena I,Wellbrock C.Phenotype plasticity as enabler of melanoma progression and therapy resistance[J].Nat Rev Cancer,2019,19(7):377-391.
[5] Harton JA,Linhoff MW,Zhang J,et al.Cutting edge:CATERPILLER:a large family of mammalian genes containing CARD,pyrin,nucleotide-binding,and leucine-rich repeat domains[J].J Immunol,2002,169(8):4088-4093.
[6] Liston A,Masters SL.Homeostasis-altering molecular processes as mechanisms of inflammasome activation[J].Nat Rev Immunol,2017,17(3):208-214.
[7] Verma D,Bivik C,Farahani E,et al.Inflammasome polymorphisms confer susceptibility to sporadic malignant melanoma:Inflammasome polymorphisms in melanoma[J].Melanoma Res,2012,25(4):506-513.
[8] Okamoto M,Liu W,Luo Y,et al.Constitutively active inflammasome in human melanoma cells mediating autoinflammation via caspase-1 processing and secretion of interleukin-1β[J].J Biol Chem,2010,285(9):6477-6488.
[9] Lee HE,Lee JY,Yang G,et al.Inhibition of NLRP3 inflammasome in tumor microenvironment leads to suppression of metastatic potential of cancer cells[J].Sci Rep,2019,9(1):12277.
[10] 关波,张松,郭舜,等.大黄素抑制胃癌细胞糖酵解并促进凋亡[J].现代生物医学进展,2018,18(13):2437-2441.
[11] 倪华,王钦.大黄素在体外诱导人肝癌Hep3b细胞凋亡的作用及机制[J].中国老年学杂志,2017,37(14):3434-3436.
[12] Lin SZ,Xu JB,Ji X,et al.Emodin inhibits angiogenesis in pancreatic cancer by regulating the transforming growth factor-β/drosophila mothers against decapentaplegic pathway and angiogenesis-associated microRNAs[J].Mol Med Rep,2015,12(4):5865-5871.
[13] 欧阳学农,房文铮,吴淡森,等.大黄素逆转非小细胞肺癌EGFR-TKI耐药的机制研究[J].临床肿瘤学杂志,2014,19(11):967-971.
[14] Ma J,Yang J,Wang C,et al.Emodin augments cisplatin cytotoxicity in platinum-resistant ovarian cancer cells via ROS-dependent MRP1 downregulation[J].Bio Res Int,2014,2014:107671.
[15] Li X,Dong Y,Wang W,et al.Emodin as an effective agent in targeting cancer stem-like side population cells of gallbladder carcinoma[J].Stem Cells Dev,2013,22(4):554-566.
[16] Zhang W,Chen H,Liu DL,et al.Emodin sensitizes the gemcitabine-resistant cell line Bxpc-3/Gem to gemcitabine via downregulation of NF-κB and its regulated targets[J].Int J Oncol,2013,42(4):1189-1196.
[17] Han JW,Shim DW,Shin WY,et al.Anti-inflammatory effect of emodin via attenuation of NLRP3 inflammasome activation[J].Int J Mol Sci,2015,16(4):8102-8109.
[18] Chen Y,Xu Y,Zhang H,et al.Emodin alleviates jejunum injury in rats with sepsis by inhibiting inflammation response[J].Biomed Pharmacother,2016,84:1001-1007.
[19] Zhu S,Wang Y,Wang X,et al.Emodin inhibits ATP-induced IL-1beta secretion,ROS production and phagocytosis attenuation in rat peritoneal macrophages via antagonizing P2X(7)receptor [J].Pharm Biol,2014,52(1):51-55.
[20] Ding Y,Liu P,Chen ZL,et al.Emodin attenuates lipopolysaccharide-induced acute liver injury via inhibiting the TLR4 signaling pathway in vitro and in vivo[J].Front Pharmacol,2018,9:962.
[21] Dai JP,Wang QW,Su Y,et al.Emodin inhibition of influenza avirus replication and influenza viral pneumonia via the Nrf2,TLR4,p38 /JNK and NF-kappaB Pathways[J].Molecules,2017,22(10):1754-1771.
[22] Awad F,Assrawi E,Louvrier C,et al.Photoaging and skin cancer:Is the inflammasome the missing link?[J].Mech Ageing Dev,2018,172:131-137.
[23] 吴树宁,王凯,施思,等.大黄素预处理对LPS/ATP诱导的人脐静脉内皮细胞焦亡的影响[J].山西医科大学学报,2019,50(4):410-414.

相似文献/References:

[1]高敏,余良,刘盛秀,等.皮肤激光共聚焦显微镜诊断和鉴别色素痣和黑素瘤评价[J].中国皮肤性病学杂志,2016,(07):699.[doi:10.13735/j.cjdv.1001-7089.201510023]
 GAO Min,YU Liang,LIU Sheng-xiu,et al.The Differential Diagnosis between Melanocytic Nevi and Melanomas using the Reflectance Confocal Microscopy[J].The Chinese Journal of Dermatovenereology,2016,(06):699.[doi:10.13735/j.cjdv.1001-7089.201510023]
[2]杨历辉,李东霞,苏依拉,等.小檗碱对人皮肤黑素瘤A375细胞周期相关miRNA的影响[J].中国皮肤性病学杂志,2016,(11):1123.[doi:10.13735/j.cjdv.1001-7089.201605119]
 YANG Li-hui,LI Dong-xia,SU Yi-la,et al.Inhibitory Effect of Berberine on Human Melanoma A375 Cells[J].The Chinese Journal of Dermatovenereology,2016,(06):1123.[doi:10.13735/j.cjdv.1001-7089.201605119]
[3]胡文婷,许爱娥.晕痣的研究进展[J].中国皮肤性病学杂志,2017,(07):800.[doi:10.13735/j.cjdv.1001-7089.201607001]
 HU Wen-ting,XU Ai-e.Research Progress in Halo Nevus[J].The Chinese Journal of Dermatovenereology,2017,(06):800.[doi:10.13735/j.cjdv.1001-7089.201607001]
[4]韩昭,张伶,刘钊,等.丹参酮ⅡA对黑素瘤A375细胞CXCR7及VEGF表达的影响[J].中国皮肤性病学杂志,2017,(11):1188.[doi:10.13735/j.cjdv.1001-7089.201706067]
 HAN Zhao,ZHANG Ling,LIU Zhao,et al.Effects of TanshinoneⅡA on CXCR7 and VEGF Expression in Malignant Melanoma A375 Cells[J].The Chinese Journal of Dermatovenereology,2017,(06):1188.[doi:10.13735/j.cjdv.1001-7089.201706067]
[5]贺勤,帅俊,陈加媛,等.转铁蛋白受体在皮肤黑素瘤中的检测[J].中国皮肤性病学杂志,2013,(04):337.
[6]汪峰,汪小柳,刘志军,等.慢病毒介导SOX9下调体外抑制人黑素瘤细胞MV3的转移潜能[J].中国皮肤性病学杂志,2019,(07):747.[doi:10.13735/j.cjdv.1001-7089.201812014]
 WANG Feng,WANG Xiaoliu,LIU Zhijun,et al.Lentivirus Mediated SOX9 Down-regulation Inhibits Metastatic Potential of Melanoma Cells MV3 in Vitro[J].The Chinese Journal of Dermatovenereology,2019,(06):747.[doi:10.13735/j.cjdv.1001-7089.201812014]
[7]龙剑文,罗晶,尹绪文.重楼皂苷Ⅰ通过抑制PI3K/Akt/mTOR通路诱导人黑素瘤A375细胞凋亡与自噬[J].中国皮肤性病学杂志,2019,(08):863.[doi:10.13735/j.cjdv.1001-7089.201812158]
 LONG Jianwen,LUO Jing,YIN Xuwen.Induces the Autophagy and Apoptosis of Melanoma A375 Cells by Suppressing PI3K/Akt/mTOR Signaling Pathway[J].The Chinese Journal of Dermatovenereology,2019,(06):863.[doi:10.13735/j.cjdv.1001-7089.201812158]
[8]李焰梅,郝丹,蒋献.大麻二酚在皮肤科的研究进展[J].中国皮肤性病学杂志,2019,(10):1202.[doi:10.13735/j.cjdv.1001-7089.201901008]
 LI Yanmei,HAO Dan,JIANG Xian.Research Progress of Cannabidiol in Dermatology[J].The Chinese Journal of Dermatovenereology,2019,(06):1202.[doi:10.13735/j.cjdv.1001-7089.201901008]
[9]陆海涛,牛刚,赵运华,等.T-钙黏蛋白对小鼠皮下氮烯咪胺耐药黑素瘤B16F10细胞株的影响[J].中国皮肤性病学杂志,2020,(05):524.[doi:10.13735/j.cjdv.1001-7089.201909108]
 LU Haitao,NIU Gang,ZHAO Yunhua,et al.The Effects of T-cadherin on Dacarbazine-resistant Subcutaneous B16F10 Melanoma in Mice[J].The Chinese Journal of Dermatovenereology,2020,(06):524.[doi:10.13735/j.cjdv.1001-7089.201909108]
[10]黄风云,胡凯,章媛华,等.KPNA2基因在皮肤黑素瘤中的表达及功能[J].中国皮肤性病学杂志,2020,(01):15.[doi:10.13735/j.cjdv.1001-7089.201903176]
 HUANG Fengyun,HU Kai,ZHANG Yuanhua,et al.Expression and Function of Gene KPNA2 in Cutaneous Malignant Melanoma[J].The Chinese Journal of Dermatovenereology,2020,(06):15.[doi:10.13735/j.cjdv.1001-7089.201903176]

备注/Memo

备注/Memo:
[基金项目] 2019 年度上海市科委医学引导类(中、西医)科技支撑项目(19411962300)
[通信作者] 刘天一,E-mail:tianyiliucn@126.com
[Corresponding author]LIU Tianyi,E-mail:tianyiliucn@126.com
更新日期/Last Update: 2020-06-05